Correlation Between Achilles Therapeutics and Lyra Therapeutics
Can any of the company-specific risk be diversified away by investing in both Achilles Therapeutics and Lyra Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Achilles Therapeutics and Lyra Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Achilles Therapeutics PLC and Lyra Therapeutics, you can compare the effects of market volatilities on Achilles Therapeutics and Lyra Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Achilles Therapeutics with a short position of Lyra Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Achilles Therapeutics and Lyra Therapeutics.
Diversification Opportunities for Achilles Therapeutics and Lyra Therapeutics
-0.66 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Achilles and Lyra is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding Achilles Therapeutics PLC and Lyra Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lyra Therapeutics and Achilles Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Achilles Therapeutics PLC are associated (or correlated) with Lyra Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lyra Therapeutics has no effect on the direction of Achilles Therapeutics i.e., Achilles Therapeutics and Lyra Therapeutics go up and down completely randomly.
Pair Corralation between Achilles Therapeutics and Lyra Therapeutics
Given the investment horizon of 90 days Achilles Therapeutics PLC is expected to generate 0.2 times more return on investment than Lyra Therapeutics. However, Achilles Therapeutics PLC is 5.11 times less risky than Lyra Therapeutics. It trades about 0.23 of its potential returns per unit of risk. Lyra Therapeutics is currently generating about -0.1 per unit of risk. If you would invest 99.00 in Achilles Therapeutics PLC on August 28, 2024 and sell it today you would earn a total of 8.00 from holding Achilles Therapeutics PLC or generate 8.08% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Achilles Therapeutics PLC vs. Lyra Therapeutics
Performance |
| Timeline |
| Achilles Therapeutics PLC |
| Lyra Therapeutics |
Achilles Therapeutics and Lyra Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Achilles Therapeutics and Lyra Therapeutics
The main advantage of trading using opposite Achilles Therapeutics and Lyra Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Achilles Therapeutics position performs unexpectedly, Lyra Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lyra Therapeutics will offset losses from the drop in Lyra Therapeutics' long position.| Achilles Therapeutics vs. Assembly Biosciences | Achilles Therapeutics vs. Spero Therapeutics | Achilles Therapeutics vs. Instil Bio | Achilles Therapeutics vs. Nuvation Bio |
| Lyra Therapeutics vs. Eliem Therapeutics | Lyra Therapeutics vs. HCW Biologics | Lyra Therapeutics vs. Scpharmaceuticals | Lyra Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |